Eli Lilly & Co. vs. Sagimet Biosciences Inc. Series A Common Stock
LLY
Eli Lilly & Co.
$1422.59 +3.56%
VS SGMTSagimet Biosciences Inc. Series A Common Stock
$9.92 -4.89%
Eli Lilly & Co. and Sagimet Biosciences Inc. Series A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | SGMT | |
|---|---|---|
| Market Cap | $1.22 trillion | $739.58 million |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | SGMT | |
|---|---|---|
| Dividend Yield | 0.49% | — |
LLY and SGMT split the dividend factors evenly.
Risk & Sentiment
| LLY | SGMT | |
|---|---|---|
| Short Interest | 1.29% | 0.46% |
SGMT leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, SGMT overview, SGMT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.